Skip to main content
Matthew Walter, MD, Oncology, Saint Louis, MO, Siteman Cancer Center

MatthewJWalterMD

Oncology Saint Louis, MO

Hematologic Oncology

Professor, Internal Medicine, Washington University School of Medicine

Dr. Walter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Walter's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1998 - 2002
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1995

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2003 - 2025
  • IL State Medical License
    IL State Medical License 2020 - 2023
  • MD State Medical License
    MD State Medical License 1999 - 2001
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGS  
    Jonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature

Abstracts/Posters

  • Mutant U2AF1S34F and U2AF1Q157P Induce Distinct RNA Splicing and Hematopoietic Phenotypes In Vivo
    Matthew J. Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
    Matthew J. Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Understanding and Targeting TP53 in Myeloid Malignancies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Translating Pathophysiological Advances Into Innovative Treatments for Myelodysplastic Syndromes and Related Myeloid Neoplasms 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising Investigators
    Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
  • $5 Million Grant Endows Research to Advance Blood Disorder Therapies
    $5 Million Grant Endows Research to Advance Blood Disorder TherapiesSeptember 11th, 2019
  • Washington University Medicine St. Louis: An Elite Investigative Hub for Acute Myeloid Leukemia
    Washington University Medicine St. Louis: An Elite Investigative Hub for Acute Myeloid LeukemiaSeptember 3rd, 2019
  • Join now to see all

Grant Support

  • Genetics Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2011–2012
  • Genetic Progression Events In Murine APLNational Heart, Lung, And Blood Institute2005–2009

Hospital Affiliations